Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study

Pathology and Oncology Research

Volumn 13, Issue 1, 2007, Pages 5-14

  Cserni, Gábor ^a   Bianchi, Simonetta ^b   Vezzosi, Vania ^b   Arisio, Riccardo ^c   Bori, Rita ^a   Peterse, Johannes L ^d   Sapino, Anna ^e   Castellano, Isabella ^e   Drijkoningen, Maria ^f   Kulka, Janina ^g   Eusebi, Vincenzo ^h   Foschini, Maria P ^h   Bellocq, Jean Pierre ⁱ   Marin, Cristi ⁱ   Thorstenson, Sten ^j   Amendoeira, Isabel ^k   Reiner Concin, Angelika ^l   Decker, Thomas ^m   Lacerda, Manuela ⁿ   Figueiredo, Paulo ⁿ   Fejes, Gábor ^a   more..

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Hospital St Anna   (Italy)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j KALMAR COUNTY HOSPITAL   (Sweden)

^k UNIVERSITY OF PORTO   (Portugal)

^l RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^m UNIVERSITY HOSPITAL MÜNSTER   (Germany)

ⁿ Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

more..

Author keywords

Breast cancer; Non sentinel lymph node; pT1; Sentinel lymph node

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROMETASTASIS; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 34250026406     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893435     Document Type: Article

References (68)

1. Moore MP, Kinne DW: Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 66: 2-6, 1997
2. Fisher B: Laboratory and clinical research in breast cancer - a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 40: 3863-3874, 1980
3. Forrest AP, Stewart HJ, Roberts MM, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196: 371-378, 1982
4. Ahlgren J, Holmberg L, Bergh J, et al: Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol 28:97-102, 2002
5. Sato K, Tamaki K, Takeuchi H, et al: Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure. Jpn J Clin Oncol 31: 318-321, 2001
6. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335-340, 1993
7. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-398, 1994
8. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818-1822, 1996
9. Al-Hilaly M, Willsher PC, Robertson JFR, et al: Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer. Eur J Surg Oncol 23: 339-340, 1997
10. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337: 956-962, 1997
11. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337: 949-955, 1997
12. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641-1648, 1999
13. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96: 115-121, 2004
14. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 6: 109-116, 1999
15. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106, 2005
16. Silverstein MJ, Lagios MD, Recht A, et al: Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201: 586-597, 2005
17. Schwartz GF, Giuliano AE, Veronesi U, et al: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94: 2542-2551, 2002
18. Pendas S, Dauway E, Giuliano R, et al: Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7: 15-20, 2000
19. Klauber-DeMore N, Tan LK, Liberman L, et al: Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7: 636-642, 2000
20. Cox CE, Nguyen K, Gray RJ, et al: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67: 513-521, 2001
21. Intra M, Zurrida S, Maffini F, et al: Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10: 1160-1165, 2003
22. Degnim AC, Griffith KA, Sabel MS, et al: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98: 2307-2315, 2003
23. Cserni G, Gregori D, Merletti F, et al: Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br J Surg 91: 1245-1252, 2004
24. Schrenk P, Konstantiniuk P, Wolfl S, et al: Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92: 707-713, 2005
25. Houvenaeghel G, Nos C, Mignotte H, et al: Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24: 1814-1822, 2006
26. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140-1151, 2003
27. Lambert LA, Ayers GD, Hwang RF, et al: Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13: 310-320, 2006
28. Smidt ML, Kuster DM, van der Wilt GJ, et al: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 12: 1066-1072, 2005
29. Kocsis L, Svébis M, Boross G, et al: Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70: 1019-1024, 2004
30. Degnim AC, Reynolds C, Pantvaidya G, et al: Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190: 543-550, 2005
31. Cserni G: Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node positive breast cancer patients. Am J Surg (in press)
32. Cserni G, Amendoeira I, Apostolikas N, et al: Pathological workup of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39: 1654-1667, 2003
33. Cserni G, Amendoeira I, Apostolikas N, et al: Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57: 695-701, 2004
34. Cserni G, Bianchi S, Boecker W, et al: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103: 358-367, 2005
35. Cserni G, Bianchi S, Vezzosi V, et al: The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol 59: 518-522, 2006
36. Perry N, Broeders M, de Wolf C, et al (Eds): European Guidelines for Breast Screening and Diagnosis. European Communities, Luxemburg, 2006
37. Sobin LH and Wittekind C (Eds): UICC TNM Classification of Malignant Tumors, 6th edition. John Wiley and Sons, Inc., New-York, 2002
38. Ellis IO, Pinder SE, Bobrow L, et al: Pathology reporting of breast disease. http://www.cancerscreening.nhs.uk/breastscreen/publications/ nhsbsp58-low-resolution.pdf. (Last assessed: 11 November 2006)
39. Tavassoli FA, Devilee P (Eds): World Health Organization: Tumors of the Breast and Female Genital Organs, 4th edition, IARC Press, Lyon, 2003
40. Greene FL, Page DL, Fleming ID, et al (Eds): AJCC Cancer Staging Handbook - TNM Classification of Malignant Tumors, 6th edition. Springer Verlag, New York, 2002
41. Hermanek P, Hutter RVP, Sobin LH, et al: Classification of isolated tumor cells and micrometastasis. Cancer 86: 2668-2673, 1999
42. Cserni G, Sapino A, Decker T: Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15: 347-354, 2006
43. Miller WG: OpenStat. http://www.statpages.org/miller/openstat/OpenStat. htm (Last assessed: 15 August 2006)
44. Cserni G, Burzykowski T, Vinh-Hung V, et al: Axillary sentinel node and tumor-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 34: 519-524, 2004
45. Woodward WA, Vinh-Hung V, Ueno NT, et al: Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24: 2910-2916, 2006
46. Cady B: New era in breast cancer. Impact of screening on disease presentation. Surg Oncol Clin N Am 6: 195-202, 1997
47. McMasters KM, Chao C, Wong SL, et al: Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95: 15-20, 2002
48. Holloway C: Surgery for ductal carcinoma in situ. Curr Probl Cancer 24: 141-162, 2000
49. Lagios MD, Silverstein MJ: Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 8: 275-277, 2001
50. Intra M, Veronesi P, Mazzarol G, et al: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138: 309-313, 2003
51. Trisal V, Qian D, Wagman LD: Axillary recurrence in DCIS: is axillary lymphadenectomy warranted? Am Surg 70: 876-880, 2004
52. Leidenius M, Salmenkivi K, von Smitten K, et al: Tumor-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 94: 380-384, 2006
53. Cserni G, Boross G, Maráz R, et al: Sentinel lymph node biopsy for in situ carcinoma of the breast. Experience at the Bacs-Kiskun County Hospital and review of the literature [In Hungarian]. Magy Seb 59: 164-172, 2006
54. Török K, Péley G, Mátrai Z, et al: The role of sentinel lymph node biopsy for staging patients with ductal carcinoma in situ of the breast. [In Hungarian] Magy Seb 59: 173-178, 2006
55. Damiani S, Ludvikova M, Tomasic G, et al: Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch 434: 227-234, 1999
56. Moran CJ, Kell MR, Kerin MJ: The role of sentinel lymph node biopsy in ductal carcinoma in situ. EJSO 31: 1105-1111, 2005
57. Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer 59: 1819-1824, 1987
58. Arisio R, Sapino A, Cassoni P, et al: What modifies the relation between tumor size and lymph node metastases in T1 breast carcinomas? J Clin Pathol 53: 846-850, 2000
59. Della Rovere GQ, Bonomi R, Ashley S, et al: Axillary staging in women with small invasive breast tumors. EJSO 32: 733-737, 2006
60. Diaz LK, Wiley EL, Venta LA: Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 173: 1303-1313, 1999
61. Diaz NM, Mayes JR, Vrcel V: Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport. Hum Pathol 36: 310-313, 2005
62. Nagi C, Bleiweiss I, Jaffer S: Epithelial displacement in breast lesions: a papillary phenomenon. Arch Pathol Lab Med 129: 1465-1469, 2005
63. Bleiweiss IJ, Nagi CS, Jaffer S: Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24: 2013-2018, 2006
64. Bleiweiss IJ: Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles. Lancet Oncol 7: 686-692, 2006
65. Viale G, Zurrida S, Maiorano E, et al: Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103: 492-500, 2005
66. Vinh-Hung V, Verschraegen C, Promish DI, et al: Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: R680-688, 2004
67. Calhoun KE, Hansen NM, Turner RR, et al: Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190: 588-591, 2005
68. van Rijk MC, Peterse JL, Nieweg OE, et al: Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107: 467-471, 2006